Compass Therapeutics' pipeline advances with tovecimig's phase 2 success in cancers. Check out why I reiterate my 'Buy' ...

The new principal of the Denise Geiger Compass Center in Leander ISD talks about the new building and the new school year.

Compass Therapeutics (CMPX) stock sees 21% surge after its Q2 2025 financials included positive trial updates on its cancer ...

Battlefield 6 has me thinking the series is actually back, but I was stunned to realize it’s hiding a very basic feature deep ...

Compass delivered a second quarter that was well received by the market, with management highlighting agent recruiting, ...

Shares of Compass Therapeutics rose after the biopharmaceutical company reported better-than-expected survival data from its continuing study of a cancer drug. The stock was up 16%, to $3.15, and have ...

The campaign supported the construction of the Marc Healing Center, Phase II of Compass Health’s Broadway Campus ...

CEO Robert Reffkin touted his brokerage hitting record numbers in metrics like revenue, market share and principal agent ...

Compass Therapeutics, Inc. ('Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.